Could a single infusion ease brain injury symptoms in veterans?
NCT ID NCT04003285
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called allopregnanolone can reduce depression and pain in veterans who have had a mild traumatic brain injury (TBI). About 132 participants will receive either the drug or a placebo through an IV. Researchers will check symptoms during the infusion and at several follow-up visits. The goal is to see if this treatment can improve daily function and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital sleep and mood programs put to the test for breast cancer survivors
- Antidepressants may rewire how the brain perceives control
- Brain scans may predict which kids respond to family therapy for depression
- Could a group therapy tackle both depression and anxiety in teens?
- What makes therapy work? study digs into the 'How' of treating anxious and depressed kids
- Brain zaps and mindfulness: a new hope for veterans in pain?